Get the Stockscreener App
2.87
4.74%
0.13
After Hours:
2.87
Artiva Biotherapeutics Inc stock is traded at $2.87, with a volume of 17,492.
It is up +4.74% in the last 24 hours and up +12.55% over the past month.
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).
See More
Previous Close:
$2.74
Open:
$2.71
24h Volume:
17,492
Relative Volume:
0.16
Market Cap:
$70.10M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-1.03%
1M Performance:
+12.55%
6M Performance:
+46.43%
1Y Performance:
-79.92%
1-Day Range:
$2.71
$2.8849
1-Week Range:
$2.71
$3.05
52-Week Range:
$1.47
$15.49
Artiva Biotherapeutics Inc Stock (ARTV) Company Profile
Name
Artiva Biotherapeutics Inc
Sector
Industry
Phone
(858) 267-4467
Address
5505 MOREHOUSE DRIVE, SAN DIEGO
Compare ARTV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARTV
Artiva Biotherapeutics Inc
|
2.87 | 66.93M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Artiva Biotherapeutics Inc Stock (ARTV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-11-25 | Resumed | H.C. Wainwright | Buy |
| Dec-30-24 | Initiated | H.C. Wainwright | Buy |
| Aug-13-24 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-13-24 | Initiated | Jefferies | Buy |
| Aug-13-24 | Initiated | Needham | Buy |
| Aug-13-24 | Initiated | TD Cowen | Buy |
| Aug-13-24 | Initiated | Wedbush | Outperform |
View All
Artiva Biotherapeutics Inc Stock (ARTV) Latest News
What momentum shifts mean for Artiva Biotherapeutics Inc.2025 Big Picture & Real-Time Stock Entry Alerts - newser.com
Multi asset correlation models including Artiva Biotherapeutics Inc.2025 Year in Review & Smart Allocation Stock Reports - newser.com
How to escape a deep drawdown in Artiva Biotherapeutics Inc.Trade Risk Summary & Safe Entry Momentum Tips - newser.com
Ranking Artiva Biotherapeutics Inc. among high performing stocks via toolsOptions Play & Advanced Swing Trade Entry Plans - newser.com
Volume spikes in Artiva Biotherapeutics Inc. stock – what they meanRisk Management & Real-Time Buy Signal Alerts - newser.com
Why Artiva Biotherapeutics Inc. stock could benefit from AI revolutionWeekly Trade Analysis & Accurate Technical Buy Alerts - newser.com
Real time alert setup for Artiva Biotherapeutics Inc. performancePortfolio Value Summary & High Conviction Investment Ideas - newser.com
Is Artiva Biotherapeutics Inc. stock recession proofMarket Activity Recap & Real-Time Volume Analysis - newser.com
Trend analysis for Artiva Biotherapeutics Inc. this weekJuly 2025 Sector Moves & Risk Controlled Stock Alerts - newser.com
Chart based analysis of Artiva Biotherapeutics Inc. trendsJuly 2025 Chart Watch & High Accuracy Investment Entry Signals - newser.com
Artiva Biotherapeutics (NASDAQ:ARTV) Receives Sell (E+) Rating from Weiss Ratings - MarketBeat
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Receives $17.00 Average Target Price from Brokerages - Defense World
Key metrics from Artiva Biotherapeutics Inc.’s quarterly dataJuly 2025 Gainers & Technical Entry and Exit Tips - newser.com
Is Artiva Biotherapeutics Inc a good long term investmentInstitutional Buying Trends & Affordable Investment Portfolio - earlytimes.in
Will Artiva Biotherapeutics Inc. stock go up soon2025 Retail Activity & Safe Investment Capital Preservation Plans - newser.com
Is Artiva Biotherapeutics Inc. trending in predictive chart modelsJuly 2025 Recap & Technical Pattern Based Buy Signals - newser.com
Artiva Biotherapeutics (NASDAQ:ARTV) Trading Down 1.7%Here's What Happened - MarketBeat
What analysts say about Artiva Biotherapeutics Inc stockEarnings Surprise Analysis & Connect With Bulls, Avoid the Bears - earlytimes.in
Combining machine learning predictions for Artiva Biotherapeutics Inc.Market Weekly Review & Verified Entry Point Signals - newser.com
Artiva Biotherapeutics Inc Stock (ARTV) Financials Data
There is no financial data for Artiva Biotherapeutics Inc (ARTV). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
5.15%
1.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):